Bardin Hill Management Partners LP Has $1.38 Million Stock Holdings in Enhabit, Inc. (NYSE:EHAB)

Bardin Hill Management Partners LP lifted its stake in shares of Enhabit, Inc. (NYSE:EHAB) by 927.4% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 174,304 shares of the company’s stock after buying an additional 157,338 shares during the period. Enhabit makes up 0.6% of Bardin Hill Management Partners LP’s investment portfolio, making the stock its 25th biggest position. Bardin Hill Management Partners LP’s holdings in Enhabit were worth $1,377,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. FMR LLC grew its holdings in shares of Enhabit by 138.4% during the 3rd quarter. FMR LLC now owns 3,388 shares of the company’s stock worth $27,000 after purchasing an additional 1,967 shares in the last quarter. Gladius Capital Management LP acquired a new stake in shares of Enhabit during the 2nd quarter worth $31,000. Quarry LP grew its holdings in shares of Enhabit by 242.2% during the 2nd quarter. Quarry LP now owns 3,703 shares of the company’s stock worth $33,000 after purchasing an additional 2,621 shares in the last quarter. Stoneridge Investment Partners LLC acquired a new stake in shares of Enhabit during the 3rd quarter worth $81,000. Finally, Canada Pension Plan Investment Board acquired a new stake in shares of Enhabit during the 2nd quarter worth $93,000.

Enhabit Trading Up 1.4 %

Shares of EHAB stock opened at $7.73 on Monday. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.85. The firm has a market capitalization of $388.70 million, a P/E ratio of -3.33 and a beta of 1.84. Enhabit, Inc. has a twelve month low of $6.85 and a twelve month high of $11.74. The stock’s fifty day simple moving average is $7.46 and its 200 day simple moving average is $8.35.

Enhabit (NYSE:EHAB) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. The business had revenue of $253.60 million during the quarter, compared to the consensus estimate of $261.69 million. During the same quarter last year, the business earned $0.03 EPS. As a group, sell-side analysts predict that Enhabit, Inc. will post 0.22 EPS for the current fiscal year.

Analyst Ratings Changes

Separately, Leerink Partners reissued a “market perform” rating and set a $8.00 target price (down from $8.50) on shares of Enhabit in a report on Tuesday, November 19th. One research analyst has rated the stock with a sell rating and six have assigned a hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $9.25.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.